Skip to main content
Log in

Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Introduction

Adrenal incidentalomas (AIs) have been associated with an increased incidence of several cardiovascular risk factors. The aim of this study was to investigate plasma adiponectin, leptin, resistin, homocysteine, high sensitive C-reactive protein levels, and carotid intima media thickness (CIMT) in patients with non-functioning AI (NFAI).

Materials and methods

This study included data from 28 patients with NFAI (Group 1) and 41 controls (Group 2). Of the patients, 50 were female and 19 were male, and the mean age was 46.7 (range 37–65) years.

Results

There were no significant differences between Group 1 and 2 in terms of age, sex, or BMI. Hypertension prevalence was significantly higher in the NFAI group than in the control group (p = 0.01). Both groups had similar lipid, blood glucose, homocysteine, uric acid, high-sensitivity CRP levels. Adiponectin, leptin, and resistin levels were similar in both groups. CIMTs were significantly higher in the NFAI group.

Conclusion

There is increasing evidence that several cardiometabolic risk factors occur with higher prevalence in non-functioning adrenal incidentaloma patients compared to age-matched healthy subjects. In our study, hypertension prevalence and CIMT were higher in the NFAI group. Serum adipokine levels were similar for both groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AI:

Adrenal incidentaloma

CIMT:

Carotid intima media thickness

CS:

Cushing’s syndrome

DM:

Diabetes mellitus

DST:

Dexamethasone suppression test

FBG:

Fasting blood glucose

HT:

Hypertension

IR:

Insulin resistance

MS:

Metabolic syndrome

NFAI:

Non-functioning adrenal incidentaloma

SCS:

Subclinical Cushing’s syndrome

References

  1. Young WF Jr (2007) Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356:601–610

    Article  CAS  PubMed  Google Scholar 

  2. Barzon L, Sonino N, Fallo F et al (2003) Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149:273–285

    Article  CAS  PubMed  Google Scholar 

  3. Mansmann G, Lau J, Balk E et al (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25:309–340

    Article  PubMed  Google Scholar 

  4. Mantero F, Arnaldi G (1999) Investigation protocol: adrenal enlargement. Clin Endocrinol (Oxf) 50:141–146

    Article  CAS  Google Scholar 

  5. Morelli V et al (2014) Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. J Clin Endocrinol Metab 99:827–834

    CAS  PubMed  Google Scholar 

  6. Reincke M, Fassnacht M, Vath S, Mora P, Allolio B (1996) Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocr Res 22:757–761

    CAS  PubMed  Google Scholar 

  7. Chiodini I, Morelli V et al (2010) Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab 95(6):2736–2745

    Article  CAS  PubMed  Google Scholar 

  8. Yenigün M, Türker T, Ataoğlu HE et al (2005) From obesity to diabetes. Haseki Tıp Bülteni 43:1–12

    Google Scholar 

  9. Steppan CM, Lazar MA (2002) Rezistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13:18–23

    Article  CAS  PubMed  Google Scholar 

  10. Mantero F, Terzolo M, Arnaldi G et al (2000) A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian society of endocrinology. J Clin Endocrinol Metab 85:637–644

    CAS  PubMed  Google Scholar 

  11. Reincke M, Nieke J, Krestin GP et al (1992) Preclinical Cushing’s syndrome in adrenal incidentalomas: comparison with adrenal Cushing’s syndrome. J Clin Endocrinol Metab 75(3):826–832

    CAS  PubMed  Google Scholar 

  12. Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419

    Article  CAS  PubMed  Google Scholar 

  13. Beşir FH, Yazgan S, Celbek G, Aydın M et al (2012) Normal values correlates’ of carotid intima- media thickness and affecting parameters in healthy adults. Anadolu Kardiyol Derg 12(5):427–433

    PubMed  Google Scholar 

  14. Zhang W, Tang ZY, Wang WQ et al (2006) Metabolic syndrome in patients with adrenocortical adenoma. Zhonghua Yi Xue Za Zhi 86:3397–3400

    CAS  PubMed  Google Scholar 

  15. Wagnerova H, Dudasova D, Lazurova I (2009) Hormonal and metabolic evaluation of adrenal incidentalomas. Neoplasma 56:521–525

    Article  CAS  PubMed  Google Scholar 

  16. Comlekci A, Yener S, Ertilav S et al (2010) Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 37(1):40–46

    Article  CAS  PubMed  Google Scholar 

  17. Garrapa G, Paola P, Gıorgıo A et al (2001) Body composition in adrenal ıncidentaloma. J Clin Endocrinol Metab 86(11):5301–5306

    CAS  PubMed  Google Scholar 

  18. Kastelein JJ, de Groot E (2008) Ultrasound imaging techniques for the evaluation of cardiovascular therapies. Eur Heart J 29:849–858

    Article  PubMed  Google Scholar 

  19. Yener S, Genc S, Akinci B et al (2009) Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma. Endocrine 35(3):365–370

    Article  CAS  PubMed  Google Scholar 

  20. Ermetici F, Malavazos AE, Corbetta S et al (2007) Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma. Metabolism 56(5):686–692

    Article  CAS  PubMed  Google Scholar 

  21. Terzolo M, Pia A, Alı A et al (2002) Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 87:998–1003

    Article  CAS  PubMed  Google Scholar 

  22. Harman E, Karadeniz M, Biray C et al (2009) The relation of adiponectin and tumor necrosis factor alpha levels between endothelial nitric oxide synthase, angiotensin-converting enzyme, transforming growth factor beta, and tumor necrosis factor alpha gene polymorphism in adrenal incidentalomas. J Endocrinol Invest 32(11):881–888

    CAS  PubMed  Google Scholar 

  23. Lazúrová I, Spišáková D, Wagnerová H et al (2011) Clinically silent adrenal adenomas—their relation to the metabolic syndrome and to GNB3 C825T gene polymorphism. Wien Klin Wochenschr 123(19–20):618–622

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was partially supported by Grants from Ankara Numune Training and Research Hospital.

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mazhar Müslüm Tuna.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tuna, M.M., Imga, N.N., Doğan, B.A. et al. Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis. J Endocrinol Invest 37, 765–768 (2014). https://doi.org/10.1007/s40618-014-0106-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-014-0106-5

Keywords

Navigation